Molecular determinants of immune response in ovarian cancer racial disparity: Can selective immunotherapy optimize therapy and close the disparity gap?

      Objective: Molecular determinants of ovarian cancer (OC) racial disparity have been under investigation in order to find avenues for improved targeted therapeutics. Our objective was to evaluate and compare the immunologic landscape of primary ovarian cancer stratified by race.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect